Author

Tanvir Ahmed

Weill Cornell MedicineORCID 0000-0002-6748-2441Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Isaac NathooiD· 2 shared Jeshua KimiD· 2 shared Jonathan Gao· 2 shared Lucas Kniess DebarbaiD· 2 shared Marcus DaSilva GoncalvesiD· 2 shared Mujmmail Ahmed· 2 shared Tiffany PerrieriD· 2 shared André Lima QueiroziD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Isaac NathooORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Intestinal fructose metabolism drives unsaturated fat absorption and synergizes with GLP-1 receptor agonism to promote weight loss

Carolina E. Echeverría, Mujmmail Ahmed, Jonathan Gao, Sarah L Stewart, Isaac Nathoo, Lucas Kniess Debarba, Carlos Lafourcade, Tanvir Ahmed, Odinakhon Shamieva, Tiffany Perrier, Chandana Prakashmurthy, Anthony Escamilla, Philip Moon, Jeshua Kim, Rachel Zwick, , M Goncalves

This study shows that inhibiting fructose metabolism via KHKi reduces weight gain and enhances weight loss when combined with GLP-1 receptor agonism in mice.

bioRxiv · Jun 8, 2026 · PreprintCell Biology

JAK1/2 Inhibition Delays Cachexia and Improves Survival through Increased Food Intake

Ezequiel Dantas, Anirudh Murthy, Jeshua Kim, Tanvir Ahmed, Mujmmail Ahmed, Tiffany Perrier, Shakti Ramsamooj, Isaac Nathoo, Lucas Kniess Debarba, André Lima Queiroz, Shiri Li, Baran A. Ersoy, Miriam Ferrer, Ido Goldstein, Jonathan Gao, , Marcus DaSilva Goncalves

This study shows that JAK1/2 inhibition with ruxolitinib improves survival and body weight in lung cancer models by increasing food intake and restoring metabolic function.

bioRxiv · Oct 21, 2025 · PreprintCancer Biology